Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease: Insights from the Ludwigshafen Risk and Cardiovascular Health cohort

2019 ◽  
Vol 120 ◽  
pp. 106566 ◽  
Author(s):  
Alexander Dressel ◽  
Burkhard Schmidt ◽  
Nina Schmidt ◽  
Ulrich Laufs ◽  
Felix Fath ◽  
...  
PLoS ONE ◽  
2014 ◽  
Vol 9 (6) ◽  
pp. e98371 ◽  
Author(s):  
Thibaut Caruba ◽  
Sandrine Katsahian ◽  
Catherine Schramm ◽  
Anaïs Charles Nelson ◽  
Pierre Durieux ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document